Congress Video

Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Efficacy Results in monarchE Cohort 1

Published: 19 May 2022

MonarchE efficacy presentation from ESMO Breast Cancer 2022, Berlin

The mention of any company, product, service, or therapy in this collection of materials does not constitute an endorsement of any kind by ESMO.

Sign up for new content alerts

Enter your email address below and we'll contact you as soon as new content is launched!

Name(Required)

HCP confirmation(Required)

I confirm that I am a healthcare professional

I have read and accept the terms of the Privacy notice and the Terms and Conditions and consent to receive e-alerts from Springer Healthcare IME pertinent to my area of interest. I can withdraw my consent at any time by contacting [email protected] or via the ‘unsubscribe’ link included in any email communications

Phone

This field is for validation purposes and should be left unchanged.

News & Resources

Congress Video

Adjuvant Abemaciclib Combined with Endocrine Therapy (ET): Efficacy Results in monarchE Cohort 1

Published: 19 May 2022

MonarchE efficacy presentation from ESMO Breast Cancer 2022, Berlin

Sign up for new content alerts

Login / register

Can you spare 2 minutes to share some feedback?